Skip to main content
English homeNews home
Story
9 of 34

Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion - Investor's Business Daily

Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion  Investor's Business Daily Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer  CNBC Red carpet style at the CFDA Fashion Awards  Reuters Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera  Barron's Pfizer is losing its fight with Novo Nordisk to get back in the obesity-drug game  MarketWatch

Latest News